Physician

David D Ingvoldstad, MD

According to 2025 Medicare claims, David Ingvoldstad, MD (NPI: 1922088673) practices ophthalmology in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Douglas, NE. This provider's primary affiliated billing organization is MIDWEST EYE CARE, PC (NPI: 1750360897; TIN: 470805428) and primary practice location at 68131-2709. Ingvoldstad is affiliated with the Nebraska Health Network, LLC (ACO ID: A3273), participating under the MSSP model.

Ingvoldstad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,134 traditional Medicare patients, billed 39,863 HCPCS/CPT codes, and received $2,323,657 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 1,367 prescription claims across 321 beneficiaries totaling $110,242 in drug costs, led by Restasis (Cyclosporine). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $83,869 to $110,242. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,129	9,158	$1,885,588
2016	1,043	8,565	$1,657,507
2017	1,122	9,273	$1,731,123
2018	1,183	9,276	$1,943,942
2019	1,030	7,681	$1,614,454
2020	1,004	8,687	$1,954,025
2021	1,092	9,410	$2,103,368
2022	1,080	10,633	$1,912,431
2023	1,031	23,073	$1,909,390
2024	1,134	39,863	$2,323,657

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	216	940	$83,869
2016	232	1,064	$87,870
2017	260	1,160	$93,042
2018	353	1,507	$118,994
2019	296	1,318	$105,774
2020	272	1,275	$106,877
2021	349	1,305	$119,523
2022	378	1,492	$142,974
2023	301	1,340	$125,605
2024	321	1,367	$110,242

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0178	Injection, aflibercept, 1 mg	133	1,166	$658
67028	Injection of drug into eye	325	1,605	$80
92014	Established patient complete exam of visual system	501	512	$78
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	565	817	$60
92134	Imaging of retina	666	2,152	$28

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Restasis	Cyclosporine	42	1,995	$41,587
Combigan	Brimonidine Tartrate/Timolol	61	2,416	$16,167
Restasis Multidose	Cyclosporine	12	500	$11,080
Prednisolone Acetate	Prednisolone Acetate	184	7,282	$5,776
Lumigan	Bimatoprost	14	501	$4,847

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for David D. Ingvoldstad, MD?

Tedicare shows public-source Medicare data for David D. Ingvoldstad, MD (NPI 1922088673), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David D. Ingvoldstad, MD have ACO affiliation data?

David D. Ingvoldstad, MD is shown with ACO affiliation data for Nebraska Health Network, LLC (MSSP, ACO ID A3273).

What billing organization is linked to David D. Ingvoldstad, MD?

David D. Ingvoldstad, MD is linked to MIDWEST EYE CARE, PC (billing NPI 1750360897) in the available physician profile data.

Does David D. Ingvoldstad, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.